Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma

This publication has 8 references indexed in Scilit:

• Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens
  Cancer, 1983
• Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)
  American Journal of Obstetrics and Gynecology, 1983
• A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer
  Gynecologic Oncology, 1983
• Ovarian Epithelial Tumors of Low Malignant Potential: A Review
  International Journal of Gynecological Pathology, 1983
• Advanced Ovarian Cancer: A Prospective Randomised Trial of Chlorambucil Versus Combined Cyclophosphamide and Cis-diamminedichloroplatinum
  Australian and New Zealand Journal of Medicine, 1982
• MEDICAL RESEARCH COUNCIL STUDY ON CHEMOTHERAPY IN ADVANCED OVARIAN CANCER
  BJOG: An International Journal of Obstetrics and Gynaecology, 1981
• Advanced ovarian cancer correlation of histologic grade with response to therapy and survival
  Cancer, 1980
• Advanced Ovarian Adenocarcinoma
  New England Journal of Medicine, 1978